Now Accepting Public Comments through June 8, 2026 on the Draft 2027 CMS QRDA III Implementation Guide, Schematron, and Sample File for Eligible Clinicians
Top
Official websites use
.gov
A .gov website belongs to an official government organization in the United States.
Secure
.gov
websites use HTTPS
A
lock
(
)
or
https://
means you’ve safely connected to the
.gov
website. Share sensitive information only on official, secure websites.
["Medication, Active": "Viloxazine"]
Performance/Reporting Period
2026
Value Set Description from VSAC
Clinical Focus: n/a
Data Element Scope: n/a
Inclusion Criteria: n/a
Exclusion Criteria: n/a
Constrained to codes in the Viloxazine value set (2.16.840.1.113883.3.464.1003.1260)
QDM Datatype and Definition
"Medication, Active"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships.
Timing:
- relevant dateTime references the time the medication is active on the medication record if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for an active medication on the medication record that is given or taken over a time interval:
- The relevantPeriod addresses:
- startTime = when the medication is first known to be used (generally the time of entry on the medication list).
- stopTime = when the medication is no longer active.
eCQMs using this data element:
Last Updated: Jul 15, 2025